SCHEMBL7657096

SCHEMBL7657096

O=C(O)CCCCOc1cccc(C=CCOC(=O)N(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.50
CYSLTR2 Q9NS75 3/20 0.48
CYSLTR1 Q9Y271 3/20 0.48
EPOR P19235 4/20 0.44
MAOB P27338 2/20 0.43
ALB P02768 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SERPINE1 P05121 1/20 0.41
FFAR1 O14842 1/20 0.41
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PKM P14618 1/20 0.40
FABP1 P07148 1/20 0.39
ALOX5 P09917 1/20 0.39
ALOX5AP P20292 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7111045 1.00 PPARA (0.50) PPARACYSLTR2CYSLTR1EPORMAOB
Tert-Butylamine SCHEMBL7653779 0.91 CYSLTR2 (0.47) PPARACYSLTR2CYSLTR1EPORMAOB
Tert-Butylamine SCHEMBL7653777 0.91 CYSLTR2 (0.47) PPARACYSLTR2CYSLTR1EPORMAOB
SCHEMBL7105134 0.87 EPOR (0.46) PPARAEPORMAOBNPC1RAB9A
SCHEMBL7105126 0.87 EPOR (0.46) PPARAEPORMAOBNPC1RAB9A
SCHEMBL7112433 0.87 EPOR (0.46) PPARAEPORMAOBNPC1RAB9A
SCHEMBL7111901 0.83 HDAC3 (0.43) EPORMAOBFFAR1
SCHEMBL7657160 0.83 HDAC3 (0.43) EPORMAOBFFAR1
SCHEMBL7653702 0.80 CYP4F2 (0.41) EPORMAOBFFAR1KDM4EALDH1A1
SCHEMBL7107398 0.80 CYP4F2 (0.41) EPORMAOBFFAR1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6335459-B1 PROSTAGLANDIN I2 RECEPTOR MODULATORS; TREATING TISSUE NECROSIS, PREMATURE UTERINE CONTRACTION, GASTRIC ULCERATION, SEXUAL DYSFUNCTION, MENSTRUAL PAIN AND IMPROPER WOUND HEALING, IMMUNOREGULATION, PLATELET AGGREGATION OR NEUTROPHIL FUNCTION SYNTEX (U.S.A.) LLC 2002-01-01 US disclosed